Author:
He Lihua,Li Sanwang,Xie Feifan,Cheng Zeneng,Ran Liling,Liu Xingling,Yu Peng
Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference10 articles.
1. Role of tyrosine kinase inhibitors in cancer therapy;Arora;J. Pharmacol. Exp. Ther.,2005
2. Protein tyrosine kinases associated with human malignancies;Comoglio;Ann. NY. Acad. Sci.,1987
3. Glivec (STI571, imatinib),a rationally developed, targeted anticancer drug;Capdeville;Nat. Rev. Drug. Discov.,2002
4. Clinical pharmacokinetics of tyrosine kinase inhibitors;van Erp;Cancer Treat. Rev.,2009
5. First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors;Nguyen;Biologics,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献